Biologically-Validated A.I. Yields Breakthrough in Cardiovascular Disease

Researchers at U.S.-based Genuity Science (formerly WuXi NextCODE) and the Yale School of Medicine published two new studies in the Journal of Experimental Medicine and Nature Metabolism on novel, artificial intelligence (A.I.) approaches that breathe new life into big data for complex diseases. See more here.